NEA Management Company’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,186,243
| Closed | -$69.1M | – | 46 |
|
|
2023
Q3 | $69.1M | Hold |
2,186,243
| – | – | 5.34% | 6 |
|
|
2023
Q2 | $56.6M | Sell |
2,186,243
-2,000,000
| -48% | -$51.7M | 4.32% | 7 |
|
|
2023
Q1 | $101M | Hold |
4,186,243
| – | – | 6.95% | 4 |
|
|
2022
Q4 | $81.6M | Sell |
4,186,243
-1,558
| -0% | -$30.4K | 4.59% | 7 |
|
|
2022
Q3 | $88M | Hold |
4,187,801
| – | – | 4.39% | 9 |
|
|
2022
Q2 | $81.5M | Hold |
4,187,801
| – | – | 4.19% | 7 |
|
|
2022
Q1 | $92.2M | Hold |
4,187,801
| – | – | 2.66% | 9 |
|
|
2021
Q4 | $66.8M | Hold |
4,187,801
| – | – | 1.35% | 14 |
|
|
2021
Q3 | $83.4M | Hold |
4,187,801
| – | – | 0.99% | 14 |
|
|
2021
Q2 | $72.4M | Hold |
4,187,801
| – | – | 0.94% | 16 |
|
|
2021
Q1 | $83M | Hold |
4,187,801
| – | – | 1.86% | 16 |
|
|
2020
Q4 | $73.1M | Hold |
4,187,801
| – | – | 1.93% | 18 |
|
|
2020
Q3 | $80.7M | Hold |
4,187,801
| – | – | 3.42% | 13 |
|
|
2020
Q2 | $81.5M | Hold |
4,187,801
| – | – | 3.28% | 14 |
|
|
2020
Q1 | $58.6M | Hold |
4,187,801
| – | – | 3.06% | 14 |
|
|
2019
Q4 | $103M | Hold |
4,187,801
| – | – | 4.86% | 10 |
|
|
2019
Q3 | $42.1M | Buy |
+4,187,801
| New | +$42.1M | 3.49% | 8 |
|